MedTrace Logo

Behçet and LDH/Albumin

NCT06276829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2024-02-26

No results posted yet for this study

Summary

ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls.

Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.

Conditions

  • Behcet's Disease
  • Albumin
  • Lactate Dehydrogenase
  • Disease Severity

Interventions

DIAGNOSTIC_TEST

LDH/albumin ratio

LDH/Albumin ratios of patient and control groups were recorded.

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2023-04-01
Completion
2023-04-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06276829 on ClinicalTrials.gov